Xin‐an Lu
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
Papers in
- Oncology 23
- CAR-T cell therapy research 20
-
- Glycosylation and Glycoproteins Research 9
- Angiogenesis and VEGF in Cancer 4
- Heat shock proteins research 3
- Co-authors
- Shang‐Cheng Hung (9 shared papers)Yan Fu (9 shared papers)Suvarn S. Kulkarni (3 shared papers)Jinq‐Chyi Lee (2 shared papers)Yongzhang Luo (5 shared papers)Yanping Ding (11 shared papers)Yuh‐Sheng Wen (1 shared paper)Lin Jia (6 shared papers)
In The Last Decade
Xin‐an Lu
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Oncology 618
- Cell Biology 226
- Organic Chemistry 349
- Molecular Biology 745
- Immunology 143
Countries citing papers authored by Xin‐an Lu
This map shows the geographic impact of Xin‐an Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin‐an Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin‐an Lu more than expected).
Fields of papers citing papers by Xin‐an Lu
This network shows the impact of papers produced by Xin‐an Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin‐an Lu. The network helps show where Xin‐an Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin‐an Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 147 | |
| 2 | 2003 | 134 | |
| 3 | 2019 | 119 | |
| 4 | 2012 | 96 | |
| 5 | 2020 | 85 | |
| 6 | 2006 | 83 | |
| 7 | 2011 | 80 | |
| 8 | 2015 | 78 | |
| 9 | 2012 | 66 | |
| 10 | 2010 | 44 | |
| 11 | 2011 | 42 | |
| 12 | 2008 | 36 | |
| 13 | 2021 | 35 | |
| 14 | 2015 | 34 | |
| 15 | 2003 | 32 | |
| 16 | 2011 | 31 | |
| 17 | 2013 | 30 | |
| 18 | 2015 | 26 | |
| 19 | 2016 | 26 | |
| 20 | 2014 | 24 |
About Xin‐an Lu
Xin‐an Lu is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Cell Biology and Electrical and Electronic Engineering, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Glycosylation and Glycoproteins Research (9 papers), Carbohydrate Chemistry and Synthesis (7 papers), Proteoglycans and glycosaminoglycans research (6 papers), Advancements in Semiconductor Devices and Circuit Design (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Heat shock proteins research (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (618 citations), Cell Biology (226 citations), Organic Chemistry (349 citations), Molecular Biology (745 citations) and Immunology (143 citations). Xin‐an Lu has collaborated with scholars based in China, Taiwan and Ethiopia. Frequent co-authors include Shang‐Cheng Hung, Yan Fu, Suvarn S. Kulkarni, Jinq‐Chyi Lee, Yongzhang Luo, Yanping Ding, Yuh‐Sheng Wen, Lin Jia, Yang Chen and Yongzhang Luo. Their work appears in journals such as Blood, Journal of the American Chemical Society, The Journal of Pathology, Journal of Clinical Oncology and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.